To further confirm whether the changes in the expression levels of these miRNAs could be used as a useful biomarker in HCV infection, we analyzed the association of the miRNA levels and clinical factors (such as ALT, AST, and liver cirrhosis) of the CHC patients. This evidence concerns the gene GPT and cryohydrocytosis.